CLAIM CARD
The cited A/B receipts support a specific working claim: Genetically determined longer telomere length was associated with lowered risk of coronary heart disease (CHD; OR = 0.95, 95% CI: 0.92-0.98); but raised risk of cancer (OR = 1.11, 95% CI: 1.06-1.16). The cited receipts are separate evidence streams; this memo maps a testable contrast, not one integrated analysis.
Evidence grade: exploratory
Contradiction status: none
Publication: 002f5fe8-38f1-4b5a-b1a1-3cdff72ddedd
Provenance: Derivation Web chain
Citation Support
source_1Telomere length and aging‐related outcomes in humans: A Mendelian randomization study in 261,000 older participantssource_2The Association of Telomere Length in Peripheral Blood Cells with Cancer Risk: A Systematic Review and Meta-analysis of Prospective Studiessource_3Rare Protein-Altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity Pneumonitissource_4Telomere Length and All-Cause Mortality: A Meta-analysissource_5Telomere length and brain aging: A systematic review and meta-analysis